"This approach should facilitate outpatient blood collection for disease screening and monitoring, particularly for underserved populations, and also serve needs of researchers and clinicians without access to centralised testing facilities. For example, this could support large-scale epidemiologic studies or remote pharmacological trials," said senior author David Kaplan, professor in the Department of Biomedical Engineering at Tufts University School of Engineering, Medford, Massachusetts, US.